Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (91-100 of 270) with videos related to

Pageof 27
Sort By:
International Journal of Laboratory Hematology|September 11, 2020
Impact of variation in reagent combinations for one-stage clotting assay on assay discrepancy in nonsevere haemophilia AAtsuo Suzuki, Nobuaki Suzuki, Takeshi Kanematsu, et al.
Cancer Genetics and Cytogenetics|August 1, 2006
Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion geneManabu Ninomiya, Akihiro Abe, Toshiya Yokozawa, et al.
Oncotarget|August 6, 2016
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinibTakanobu Morishita, Fumihiko Hayakawa, Keiki Sugimoto, et al.
Cancer Science|June 22, 2016
Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromesYasuhiro Suzuki, Akihiro Tomita, Fumika Nakamura, et al.
Cancer Science|December 24, 2009
Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rgammac-/- miceRyohei Tanizaki, Yuka Nomura, Yasuhiko Miyata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutationsHitoshi Kiyoi, Yukimasa Shiotsu, Kazutaka Ozeki, et al.
Molecular Cancer Therapeutics|October 13, 2023
Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor ModelsKanae Imai, Yuki Takeuchi, Seitaro Terakura, et al.
Cancer Science|October 20, 2024
Spheroid culture to select theoretical therapeutic drugs in intravascular large B-cell lymphomaMika Takai, Kazuyuki Shimada, Katsuya Furukawa, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2021
Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massilienseKeisuke Oka, Hiroshi Morioka, Motoki Eguchi, et al.
Thrombosis Journal|January 25, 2023
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patientsNaruko Suzuki, Nobuaki Suzuki, Yuka Kawaguchi, et al.
Pageof 27

Showing results (91-100 of 270) with videos related to

Sort By:
Pageof 27
International Journal of Laboratory Hematology|September 11, 2020
Impact of variation in reagent combinations for one-stage clotting assay on assay discrepancy in nonsevere haemophilia AAtsuo Suzuki, Nobuaki Suzuki, Takeshi Kanematsu, et al.
Cancer Genetics and Cytogenetics|August 1, 2006
Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion geneManabu Ninomiya, Akihiro Abe, Toshiya Yokozawa, et al.
Oncotarget|August 6, 2016
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinibTakanobu Morishita, Fumihiko Hayakawa, Keiki Sugimoto, et al.
Cancer Science|June 22, 2016
Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromesYasuhiro Suzuki, Akihiro Tomita, Fumika Nakamura, et al.
Cancer Science|December 24, 2009
Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rgammac-/- miceRyohei Tanizaki, Yuka Nomura, Yasuhiko Miyata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutationsHitoshi Kiyoi, Yukimasa Shiotsu, Kazutaka Ozeki, et al.
Molecular Cancer Therapeutics|October 13, 2023
Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor ModelsKanae Imai, Yuki Takeuchi, Seitaro Terakura, et al.
Cancer Science|October 20, 2024
Spheroid culture to select theoretical therapeutic drugs in intravascular large B-cell lymphomaMika Takai, Kazuyuki Shimada, Katsuya Furukawa, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2021
Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massilienseKeisuke Oka, Hiroshi Morioka, Motoki Eguchi, et al.
Thrombosis Journal|January 25, 2023
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patientsNaruko Suzuki, Nobuaki Suzuki, Yuka Kawaguchi, et al.
Pageof 27